<PAGE> 1
==============================================================================
FORM 8-K
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported):
March 3, 2000
Commission File No.: 0-14685
GENICOM CORPORATION
(Exact name of registrant as specified in its charter)
<TABLE>
<S> <C>
DELAWARE 51 - 0271821
(State or other jurisdiction of (I.R.S.
incorporation or Employer
organization) Identification No.)
14800 CONFERENCE CENTER DRIVE
SUITE 400, WESTFIELDS
CHANTILLY, VIRGINIA
(Address of principal 20151
executive offices) (Zip Code)
</TABLE>
Registrant's telephone number, including area code: (703) 802-9200
==============================================================================
<PAGE> 2
GENICOM CORPORATION AND SUBSIDIARIES
FORM 8-K
Item 5. Other Items
GENICOM Corporation today announced that Shaun Donnellan has been
appointed President and Chief Executive Officer of the Company,
replacing Paul T. Winn. James C. Gale, who has been serving as the
Company's Senior Vice President Chief Financial Officer, is also
being replaced. In addition, the Company stated that its lender
group had released an amount sufficient to fund the Company's
payroll for March 3, 2000. As previously announced, since February
25, 2000 when it gave the Company formal notice of default under
the credit facility, the lender group has been exercising its
offset rights against the Company's operating accounts.
Mr. Donnellan is a principal of Glass & Associates, Inc. (Glass),
one of the nation's leading turnaround management consulting
firms. Glass has been serving as a consultant to GENICOM, and as a
result, Mr. Donnellan is familiar with the operations of the
Company.
The statements contained in this release which are not historical
facts are forward looking statements that involve risks and
uncertainties, including, but not limited to the Company's
continued losses and absence of lenders' support which could
affect the Company's ability to maintain itself as a going concern
or make the initiation of bankruptcy proceedings appropriate, the
results of the negotiations with the lending syndicate, the
Company's relationship with Compaq, the Company's ability to
secure new customers and maintain its current customer base, the
risk of customer delays or cancellations in both on-going and new
programs, supplier disruptions, the effect of economic conditions,
the impact of competition and other risks detailed, from time to
time, in the Company's Securities and Exchange Commission filings.
<PAGE> 3
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
GENICOM Corporation
--------------------------
Registrant
Date: March 3, 2000
/s/ Shaun Donnellan
--------------------------
Signature
Shaun Donnellan
President and Chief
Executive Officer
(Mr. Donnellan has been
duly authorized to sign
on behalf of the
Registrant)
